Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 6.85 ($0.09) and traded as low as GBX 6.70 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares traded.
Venn Life Sciences Stock Performance
The business’s 50-day moving average price is GBX 6.85 and its two-hundred day moving average price is GBX 6.85. The company has a market capitalization of £4.89 million and a P/E ratio of -2.14. The company has a debt-to-equity ratio of 35.83, a current ratio of 2.30 and a quick ratio of 1.48.
About Venn Life Sciences
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Featured Stories
- Five stocks we like better than Venn Life Sciences
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- How Can Investors Benefit From After-Hours Trading
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- What does consumer price index measure?
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
